Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
E. Badr, M. Yousif, S. Hazzaa (Shebin El-Kom, Egypt). Lipoprotein-associated phospholipase A₂ levels as a predictor of cardiovascular risks in patients with COPD and obstructive sleep apnea. Eur Respir J 2013; 42: Suppl. 57, 3052

Member's Comments

Maha Yousif - 10.10.2013 17:32
informative

Related content which might interest you: Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015 Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications Year: 2016 Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD) Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA) Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015 The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013 C-reactive protein (CRP) and prevalence of cardiovascular diseases in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007